Evidence map›Paper›PMID 42256974›Full record

ArticleClinical case reports2026

Early-Onset Mucocutaneous Findings and Isolated Progressive Thrombocytopenia in a Child With a DKC1 A353V Variant.

Harun Kasapoğlu, Aslı Turgutoğlu Yılmaz, Berkin Berk Akbeyaz, Neslihan Çalışkan, Yılmaz Ay

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Harun KasapoğluDepartment of Pediatric Hematology and Oncology Kartal Dr. Lutfi Kirdar City Hospital Istanbul Turkey.ORCID https://orcid.org/0000-0002-5034-9310
Aslı Turgutoğlu YılmazDepartment of Pediatric Hematology and Oncology Kartal Dr. Lutfi Kirdar City Hospital Istanbul Turkey.ORCID https://orcid.org/0000-0002-2320-8766
Berkin Berk AkbeyazDepartment of Pediatric Hematology and Oncology Kartal Dr. Lutfi Kirdar City Hospital Istanbul Turkey.ORCID https://orcid.org/0000-0002-7918-7407
Neslihan ÇalışkanDepartment of Pediatric Hematology and Oncology Kartal Dr. Lutfi Kirdar City Hospital Istanbul Turkey.ORCID https://orcid.org/0000-0001-5487-9485
Yılmaz AyDepartment of Pediatric Hematology and Oncology Kartal Dr. Lutfi Kirdar City Hospital Istanbul Turkey.ORCID https://orcid.org/0000-0003-0397-6669

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyskeratosis congenita (DC) is a rare telomere biology disorder characterized by mucocutaneous abnormalities and progressive bone marrow failure. We report a 10-year-old boy with a hemizygous DKC1 c.1058C > T (p.Ala353Val) variant who presented with unusually early mucocutaneous findings, including oral leukoplakia at 2 years of age, followed by reticular skin hyperpigmentation, nail dystrophy, and later isolated, slowly progressive thrombocytopenia. Bone marrow examination revealed hypocellularity with reduced granulocytic and megakaryocytic precursors, supporting an inherited bone marrow failure syndrome, which was confirmed by genetic analysis. Hemoglobin and leukocyte counts remained stable during follow-up, and no transfusion requirement occurred. This case highlights that early mucocutaneous manifestations and isolated thrombocytopenia may represent initial features of DKC1-related DC, emphasizing the importance of early recognition and long-term multidisciplinary surveillance.

Indexed as

bone marrow failureDKC1 A353Vdyskeratosis congenitaoral leukoplakiatelomere biology disorderthrombocytopenia

Identifiers

PMID42256974
PMCPMC13239218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.